Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;27(7):euaf128.
doi: 10.1093/europace/euaf128.

The extravascular implantable defibrillator: a novel opportunity for the paediatric population

Mauro Biffi  1 , Andrea Quaranta  2 , Alessandro Carecci  2 , Luca Ragni  1 , Andrea Donti  1 , Cristian Martignani  1 , Igor Diemberger  2 , Andrea Angeletti  1 , Matteo Ziacchi  1
Affiliations

The extravascular implantable defibrillator: a novel opportunity for the paediatric population

Mauro Biffi et al. Europace. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none declared.

Figures

Figure 1
Figure 1
(A, B) Implant in a 12 years old boy with hypertrophic cardiomyopathy. See Ring 1 and 2 in front of the RV, the abdominal loop, and the intermuscular placement. (C) Trend of mean R-wave amplitude, from implantation to last follow-up. (D) Body habit and ventricular function. (E) 16 years old girl with desmoplakin-related arrhythmogenic cardiomyopathy, cluster of NSVTs (Non Sustained Ventricular Tachycardia) followed by VT terminated by ATP. ATP, anti-tachycardia pacing; RV, right ventricle.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP et al. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl J Med 2022;387:1292–302. - PubMed
    1. Quaranta A, Carecci A, Lazzeri M, Bertelli M, Angeletti A, Spadotto A, et al. Lead placement in extravascular ICD recipients: the first step to prevent P-wave oversensing. Eur Heart J 2023;44:ehad655.678.
    1. Carecci A, Lazzeri M, Quaranta A, Bertelli M, Spadotto A, Angeletti A et al. Intermuscular placement and defibrillation with the extravascular ICD: a single-centre experience. Eur Heart J 2023;44:ehad655.676
    1. Crozier I, Murgatroyd F, Amin A, Clementy N, Duncker D, Kotschet E et al. Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary enlighten study results and meta-analysis. Heart Rhythm 2025:S1547-5271(25)00127-4. - PubMed
    1. Thuraiaiyah J, Philbert BT, Jensen AS, Xing LY, Joergensen TH, Lim CW et al. Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention. Europace. 2024;26:euae245. - PMC - PubMed

LinkOut - more resources